Published on 13 Jun 2024
Sci & TechHEALTH
SCIENCE
TECHNOLOGY
Antibodies are protective proteins produced by your immune system. They attach to antigens (foreign substances) and remove them from your body.
Broadly neutralizing antibodies (bNAbs) was a type of antibody discovered in the 1990s from a small subset of HIV-infected individuals
They can recognize and block many types of human immunodeficiency virus (HIV) from entering healthy cells.
They may also activate other immune cells to help destroy HIV-infected cells.
Researchers are investigating whether bNAbs could be used to develop a therapeutic HIV vaccine.
The germline-targeting strategy is the one approach where immunologists are using for development of B Cell based HIV vaccine.
Germline-targeting
Germline targeting, uses a series of primer and booster vaccines to train B cells to recognise HIV and produce broadly neutralising antibodies (bnAbs) that can deactivate the virus.
The B Cells, also known as B-lymphocytes are a type of specialised white blood cells that produce antibody proteins in response to pathogens.
Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013
2+2 Ministerial Dialogue
Civil Registration System
Brown Trout
Bonnet Macaques
New Aspergillus Species Discovered in Western Ghats
Ragging in Campus
Time Use Survey 2024
Amir Khusrau and Persian Influence in Indian Culture